HIMALAYA NUTRAVEDICS INDIA LIMITED IPO
HIMALAYA NUTRAVEDICS INDIA LIMITED IPO closed on 24 Sept 2026. Allotment 25 Sept 2026, listing 29 Sept 2026. Price band ₹100–₹106, lot 1200 shares, GMP +₹0 (0%). Track allotment on Allotly.
| Status | Closed |
|---|---|
| Category | SME · BSE |
| Price band | ₹100–₹106 |
| Lot size | 1200 shares |
| Minimum investment | ₹2,54,400 |
| Issue size | ₹26.5 Cr |
| GMP | +₹0 (0%) |
| Open date | 22 Sept 2026 |
| Close date | 24 Sept 2026 |
| Allotment date | 25 Sept 2026 |
| Listing date | 29 Sept 2026 |
About HIMALAYA NUTRAVEDICS INDIA LIMITED
Himalaya Nutravedics manufactures and supplies a range of Ayurvedic and nutraceutical products across multiple dosage forms, including softgel capsules, hardgel capsules, tablets, liquid orals, medicated oils, and protein powders. The company operates through a single integrated manufacturing facility located in Hyderabad, Telangana. Its product portfolio covers therapeutic categories such as pain management, infertility, women’s wellness, gut health, neurological support, and general wellness. The business generates revenue primarily from the sale of Ayurvedic formulations, alongside nutraceutical offerings. The company operates mainly through a business-to-business model, supplying products to stockists, distributors, and third-party contract manufacturing clients across various states in India. It also undertakes custom contract manufacturing for corporate clients under their own…
Strengths
- Integrated manufacturing facility capable of producing multiple dosage forms.
- Diverse Ayurvedic and nutraceutical product portfolio across key therapeutic areas.
- Established B2B distribution network with presence across 17 Indian states.
- Track record of strong revenue and net profit growth over recent fiscal years.
- In-house quality assurance and control capabilities across production processes.
Risks
- High revenue reliance on Ayurvedic products, accounting for over 90% of sales.
- Significant revenue concentration from top 10 customers representing over 80% of revenue.
- Operations from a single leased manufacturing facility located in Hyderabad, Telangana.
- Pending trademark opposition proceedings for corporate logos and mark applications.
- History of negative cash flows from operating activities due to working capital needs.